摘要
14例新生儿糖尿病(neonatal diabetes mellitus)入选,比较胰岛素(n=5)和格列本脲(n=9)的疗效。扩增6例患儿KCNJll、ABCC8、INS基因并测序。共发现2例存在ABCC8基因突变,1例KCNJIl基因突变,1例为INS基因突变,1例为6q24甲基化减低,1例突变基因不清。9例新生儿糖尿病格列本脲治疗者8例血糖控制良好(88.9%)。5例采用胰岛素治疗后均失访或死亡。提示新生儿糖尿病胰岛素治疗依从性差,格列本脲可有效降低血糖。
Fourteen neonatal diabetes mellitus (NDM)patients were recruited. 9 patients were treated with glyburide and the other 5 with insulin. ABCC8, KCNJ11, and INS genes were sequenced in 6 of them. Gene mutations were found in 2, 1, and 1 cases in these genes, respectively. One case with 6q24 hypomethylation and another without known mutation were also found. 8 out of 9 patients treated with glyburide reached euglycemia (88.9%). The other 5 patients with insulin therapy either died or lost contact. The results suggest that glyburide therapy is effective in neonatal diabetes mellitus, while insulin therapy may contribute to poor compliance.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2011年第6期488-491,共4页
Chinese Journal of Endocrinology and Metabolism